Completed PHASE2 INTERVENTIONAL 2-arm NCT01428804

Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression (DEPRESCO)

Pilot Study of Feasibility of the Effect of Treatment With tDCS in Patients Suffering From Resistant Depression

Sponsor: Centre Hospitalier Universitaire de Besancon

Interventions transcranial Direct Current Stimulation (tDCS)

Updated 6 times since 2017 Last updated: Aug 22, 2016 Started: Jun 30, 2011 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Resistant Major Depression and is currently completed. Centre Hospitalier Universitaire de Besancon leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Besancon
H. Lundbeck A/S

Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Besançon, France